Vanguard Group
TNYA icon

Vanguard Group’s Tenaya Therapeutics TNYA Stock Holding History

Vanguard Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.09M Buy
8,560,108
+3,495,251
+69% +$4.75M ﹤0.01% 3176
2025
Q3 		$8.21M Buy
5,064,857
+309,530
+7% +$312K ﹤0.01% 3079
2025
Q2 		$2.91M Buy
4,755,327
+673,295
+16% +$343K ﹤0.01% 3395
2025
Q1 		$2.33M Buy
4,082,032
+809,988
+25% +$799K ﹤0.01% 3450
2024
Q4 		$4.68M Buy
3,272,044
+58,877
+2% +$132K ﹤0.01% 3298
2024
Q3 		$6.2M Buy
3,213,167
+48,901
+2% +$138K ﹤0.01% 3176
2024
Q2 		$9.81M Buy
3,164,266
+301,350
+11% +$1.24M ﹤0.01% 2939
2024
Q1 		$15M Buy
2,862,916
+403,472
+16% +$1.93M ﹤0.01% 2737
2023
Q4 		$7.97M Buy
2,459,444
+291,576
+13% +$629K ﹤0.01% 3075
2023
Q3 		$5.53M Buy
2,167,868
+168,489
+8% +$705K ﹤0.01% 3205
2023
Q2 		$11.7M Buy
1,999,379
+131,752
+7% +$766K ﹤0.01% 2851
2023
Q1 		$5.32M Buy
1,867,627
+251,411
+16% +$706K ﹤0.01% 3281
2022
Q4 		$3.25M Buy
1,616,216
+555,651
+52% +$1.36M ﹤0.01% 3484
2022
Q3 		$3.08M Sell
1,060,565
-2,971
-0.3% -$13.9K ﹤0.01% 3577
2022
Q2 		$5.99M Sell
1,063,536
-22,127
-2% -$179K ﹤0.01% 3277
2022
Q1 		$12.8M Buy
1,085,663
+528,845
+95% +$6.4M ﹤0.01% 3022
2021
Q4 		$10.6M Buy
556,818
+53,830
+11% +$1.17M ﹤0.01% 3172
2021
Q3 		$10.4M Buy
+502,988
New +$10.8M ﹤0.01% 3222

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group's TNYA Position: Q4 2025 in Review

Vanguard Group increased its Tenaya Therapeutics (TNYA) stake by 69% in Q4 2025, buying an estimated $4.75M and bringing the position to 8,560,108 shares worth $6.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

Vanguard Group first reported a position in TNYA in Q3 2021 and has held it in 18 quarters since. The position peaked at $15M in Q1 2024. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Vanguard Group held 8,560,108 shares of Tenaya Therapeutics worth $6.09M as of Q4 2025.
  • Vanguard Group bought 3,495,251 Tenaya Therapeutics shares in Q4 2025, an estimated $4.75M.
  • Tenaya Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3176 holding.
  • Vanguard Group first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Tenaya Therapeutics position peaked at $15M in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.